Plasma constitutes about 55% blood by volume and carries more than a thousand proteins and other substances like electrolytes, hormones which are required for the optimal function of the human body and hence is an important component of blood. Albumin is one of the major proteins which constitutes around 60 % of the total protein in the plasma. In plasma fractionation blood is split into its constituents of the plasma and RBCs, WBCs and platelets.
Plasma Fractionation Market: Drivers & Restraints The growth of the Latin America Plasma Fractionation industry is mainly driven by rising cases of immune and bleeding disorders, growing incidence of Alpha-1 Antitrypsin deficiency and the increasing use of immunoglobulin. Also increasing aging population with blood related diseases is boosting the growth of Latin America Plasma Fractionation market. As for the restraints of the market, High Costs and reimbursement issues are the major hindrances limiting the growth of this industry.
Plasma Fractionation Market: Overview Among the product segment immunoglobin is expected to have the major share in the market in 2016 because of factors like increase in neurological and immunology diseases, growing off-label indications of intravenous immunoglobulin, and increased use of subcutaneous immunoglobulin due to its ease of administration and reduced administration time.
Plasma Fractionation Market: Region-wise Outlook Based on Geography the Latin America Cell Expansion market is segmented into Brazil, Mexico, Argentina, and remaining countries of South America. Brazil dominates the market followed by Mexico, Argentina, and Columbia.
Key Questions Answered What is the current and future Plasma Fractionation Market outlook in Latin America? What trends are affecting the market? What is the competitive landscape and market share of major players in the Plasma Fractionation Market space in Latin America? What are the key, high growth markets that Plasma Fractionation Market manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Plasma Fractionation currently on the market? How will emerging technologies fulfil these unmet needs? What is patient perception and market outlook of Plasma Fractionation? What are the challenges and barriers that have hindered widespread adoption of Plasma Fractionation?
Plasma Fractionation Market: Key Players Some of the key players in the Latin America Plasma Fractionation market are Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), CSL Ltd. (Australia), Grifols S.A (Spain), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Franηais du Fractionnement et des Biotechnologies (France).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
